阿泰生命科学 ATAI
美股生物科技
$0.00 +$0.00 (0.00%)
休市 · Nov 6, 9:30 am ET
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值–
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.70M+137.0% YoY
营业利润-$41.72M-65.3% YoY
净利润-$32.55M-17.3% YoY
摊薄每股收益-$0.09+35.7% YoY
自由现金流-$35.27M-148.0% YoY
经营现金流-$35.27M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-3,122.6%
净利率-14,941.7%
净资产收益率-417.5%
资产收益率-294.4%
投入资本回报率-403.9%
流动比率8.58
负债/资产比率33.4%
现金及投资$225.81M
总负债$1.57M
净现金（净负债）$224.24M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $1.70M | $954,000.00 | $4.09M | $1.07M | $749,000.00 |
| 营业总收入 | $1.70M | $954,000.00 | $4.09M | $1.07M | $749,000.00 |
| 营业费用 | $43.43M | $31.11M | $117.44M | $40.42M | $29.16M |
| 销售及管理费用 | $17.77M | $14.44M | $65.09M | $25.09M | $14.51M |
| -管理费用 | $17.77M | $14.44M | $65.09M | $25.09M | $14.51M |
| 研发费用 | $28.07M | $17.41M | $53.06M | $15.96M | $14.68M |
| 其他营业费用 | -$2.42M | -$742,000.00 | – | – | -$29,000.00 |
| 营业利润 | -$41.72M | -$30.16M | -$113.35M | -$39.35M | -$28.41M |
| 非经营性利息净收入（支出） | $79,000.00 | $78,000.00 | $316,000.00 | $542,000.00 | $504,000.00 |
| 非经营性利息收入 | $79,000.00 | $78,000.00 | $1.48M | $540,000.00 | $504,000.00 |
| 非经营性利息支出 | $0.00 | $0.00 | $1.16M | -$2,000.00 | $0.00 |
| 其他收入（支出） | $9.16M | $299,000.00 | -$546.82M | -$506.11M | -$33.06M |
| 证券出售收益 | $9.99M | $2.18M | -$18.71M | $20.69M | -$32.61M |
| 特殊收益（费用） | $0.00 | – | -$525.52M | -$524.20M | $0.00 |
| 其他非经营性收入（支出） | -$828,000.00 | -$1.88M | -$2.59M | -$2.60M | -$451,000.00 |
| 税前利润 | -$32.48M | -$29.78M | -$659.85M | -$544.92M | -$60.97M |
| 税费 | $64,000.00 | $20,000.00 | $298,000.00 | -$82,000.00 | $131,000.00 |
| 净利润 | -$32.55M | -$29.80M | -$660.15M | -$544.84M | -$61.10M |
| 持续经营利润 | -$32.55M | -$29.80M | -$660.15M | -$544.84M | -$61.10M |
| 少数股东权益 | -$24,000.00 | -$20,000.00 | -$100,000.00 | -$25,000.00 | -$24,000.00 |
| 归属母公司净利润 | -$32.52M | -$29.78M | -$660.05M | -$544.81M | -$61.07M |
| 归属普通股股东净利润 | -$32.52M | -$29.78M | -$660.05M | -$544.81M | -$61.07M |
| 基本每股收益 | -$0.09 | -$0.08 | -$2.91 | -$1.73 | -$0.28 |
| 摊薄每股收益 | -$0.09 | -$0.08 | -$2.91 | -$1.73 | -$0.28 |
| 其他税费 | – | – | -$714,000.00 | – | – |
| -减：其他特殊支出 | – | – | $524.82M | $523.51M | – |
| -业务出售收益 | – | – | $0.00 | – | – |
| -固定资产出售收益 | – | – | -$692,000.00 | – | – |
| 权益法投资税后收益 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $264.79M | $264.88M | $292.72M | $292.72M | $239.82M |
| 流动资产合计 | $244.75M | $250.07M | $275.68M | $275.68M | $130.67M |
| 现金及现金等价物与短期投资 | $225.81M | $230.77M | $256.04M | $256.04M | $114.61M |
| -现金及现金等价物 | $168.81M | $43.10M | $85.30M | $85.30M | $30.40M |
| -短期投资 | $57.00M | $187.67M | $170.74M | $170.74M | $84.20M |
| 应收款 | $10.70M | $14.71M | $14.43M | $14.43M | $11.07M |
| -应收账款 | $647,000.00 | $864,000.00 | $667,000.00 | $667,000.00 | – |
| -应收票据 | $107,000.00 | $691,000.00 | $625,000.00 | $625,000.00 | $10.16M |
| -应收税款 | $9.94M | $13.15M | $13.14M | $13.14M | $907,000.00 |
| 预付资产 | $6.53M | $2.85M | $4.27M | $4.27M | $3.99M |
| 其他流动资产 | $1.72M | $1.74M | $946,000.00 | $946,000.00 | $1.00M |
| 非流动资产合计 | $20.04M | $14.81M | $17.04M | $17.04M | $109.15M |
| 固定资产净值 | $3.65M | $3.86M | $4.01M | $4.01M | $5.67M |
| -固定资产原值 | $4.27M | $4.35M | $4.42M | $4.42M | $6.41M |
| -累计折旧 | -$617,000.00 | -$485,000.00 | -$405,000.00 | -$405,000.00 | -$733,000.00 |
| 投资及预付款 | $5.86M | $6.77M | $8.74M | $8.74M | $88.36M |
| 商誉及其他无形资产 | $3.03M | $3.09M | $3.18M | $3.18M | $14.74M |
| -商誉 | $331,000.00 | $331,000.00 | $331,000.00 | $331,000.00 | $331,000.00 |
| -其他无形资产 | $2.70M | $2.76M | $2.85M | $2.85M | $14.41M |
| 其他非流动资产 | $7.50M | $1.09M | $1.11M | $1.11M | $382,000.00 |
| 负债合计 | $88.36M | $66.10M | $70.72M | $70.72M | $79.91M |
| 流动负债合计 | $28.53M | $24.96M | $23.48M | $23.48M | $16.54M |
| 应付款 | $11.61M | $10.86M | $4.93M | $4.93M | $5.41M |
| -应付账款 | $11.49M | $10.79M | $4.91M | $4.91M | $5.37M |
| -应付税款合计 | $114,000.00 | $75,000.00 | $20,000.00 | $20,000.00 | $43,000.00 |
| 一年内应计费用 | $13.06M | $9.59M | $13.61M | $13.61M | $9.93M |
| 短期债务及融资租赁负债 | $314,000.00 | $310,000.00 | $271,000.00 | $271,000.00 | $532,000.00 |
| -一年内到期融资租赁负债 | $314,000.00 | $310,000.00 | $271,000.00 | $271,000.00 | $532,000.00 |
| 一年内递延负债 | $632,000.00 | $1.48M | $1.52M | $1.52M | – |
| 其他流动负债 | $2.92M | $2.72M | $3.14M | $3.14M | $665,000.00 |
| 非流动负债合计 | $59.82M | $41.13M | $47.24M | $47.24M | $63.37M |
| 长期债务及融资租赁负债 | $1.57M | $1.69M | $1.80M | $1.80M | $2.43M |
| -长期融资租赁负债 | $1.57M | $1.69M | $1.80M | $1.80M | $2.43M |
| 衍生产品负债 | $57.21M | $38.40M | $44.38M | $44.38M | $57.43M |
| 其他非流动负债 | $1.04M | $1.05M | $1.06M | $1.06M | $3.51M |
| 股东权益合计 | $176.44M | $198.78M | $222.00M | $222.00M | $159.91M |
| 股东权益 | $176.37M | $198.68M | $221.87M | $221.87M | $159.75M |
| 股本 | $3.69M | $3.66M | $3.63M | $3.63M | $26.78M |
| -普通股 | $3.69M | $3.66M | $3.63M | $3.63M | $26.78M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | – |
| 资本公积 | $1.62B | $1.61B | $1.60B | $1.60B | $969.38M |
| 留存收益 | -$1.42B | -$1.39B | -$1.36B | -$1.36B | -$815.44M |
| 不影响留存收益的损益 | -$20.47M | -$20.60M | -$20.93M | -$20.93M | -$20.96M |
| 少数股东权益 | $71,000.00 | $96,000.00 | $127,000.00 | $127,000.00 | $157,000.00 |
| 受限现金 | – | – | $0.00 | $0.00 | $0.00 |
| -可供出售证券 | – | – | – | – | $53.95M |
| -长期股权投资 | – | – | – | – | $34.41M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$35.27M | -$21.09M | -$102.68M | -$47.48M | -$23.26M |
| 持续经营经营活动现金流净额 | -$35.27M | -$21.09M | -$102.68M | -$47.48M | -$23.26M |
| 持续经营净利润 | -$32.55M | -$29.80M | -$660.15M | -$544.84M | -$61.10M |
| 持续经营损益 | $2,000.00 | $372,000.00 | $521.88M | $522.00M | $4.30M |
| 折旧、折耗与摊销 | $215,000.00 | $167,000.00 | $1.01M | $336,000.00 | $233,000.00 |
| 其他非现金项目 | -$8.46M | -$1.26M | $26.81M | -$20.02M | $31.46M |
| 营运资金变动 | -$2.83M | $2.02M | -$6.48M | -$11.29M | -$1.26M |
| -预付资产变动 | -$241,000.00 | $183,000.00 | $691,000.00 | -$1.22M | $427,000.00 |
| -应付账款及应计费用变动 | $4.77M | $1.85M | -$7.93M | -$10.84M | -$2.22M |
| -其他营运资金变动 | -$7.36M | -$19,000.00 | $766,000.00 | – | – |
| 投资活动现金流净额 | $158.59M | -$21.65M | -$109.13M | -$40.34M | -$67.55M |
| 持续经营投资活动现金流净额 | $158.59M | -$21.65M | -$109.13M | -$40.34M | -$67.55M |
| 固定资产购置及出售净额 | $0.00 | $0.00 | -$901,000.00 | -$110,000.00 | $4.60M |
| 投资购置及出售净额 | $158.59M | -$21.65M | -$92.90M | -$47.87M | -$49.94M |
| 筹资活动现金流 | $2.64M | $821,000.00 | $269.48M | $142.38M | $59.74M |
| 持续经营筹资活动现金流净额 | $2.64M | $821,000.00 | $269.48M | $142.38M | $59.74M |
| 普通股发行净额 | $0.00 | $0.00 | $251.49M | $139.06M | $36.44M |
| 股票期权行使所得 | $2.64M | $821,000.00 | $31.94M | $24.81M | -$6.06M |
| 期末现金余额 | $168.81M | $43.10M | $85.30M | $85.30M | $30.40M |
| 现金净变动 | $125.95M | -$41.92M | $57.68M | $54.55M | -$31.07M |
| 期初现金余额 | $43.10M | $85.30M | $27.51M | $30.40M | $61.94M |
| 汇率变动影响 | -$248,000.00 | -$276,000.00 | $116,000.00 | $346,000.00 | -$468,000.00 |
| 自由现金流 | -$35.27M | -$21.09M | -$113.54M | -$47.59M | -$28.62M |
| 无形资产购置及出售净额 | – | $0.00 | -$9.97M | $0.00 | – |
| 资本支出 | – | – | $0.00 | $0.00 | $0.00 |
| 业务购买及出售净额 | – | – | $4.64M | $7.64M | -$2.25M |
| 其他投资变动净额 | – | – | -$10.00M | $0.00 | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | $21.81M |
| 其他筹资费用净额 | – | – | -$13.95M | $0.00 | – |
暂无评论——快来第一个聊聊 ATAI。
登录后参与讨论。